Colon and Rectal Cancer

• Worldwide comparison of colorectal cancer survival, by topography and stage at diagnosis (CONCORD-2)
• Increasing colorectal cancer incidence among young adults in England diagnosed during 2001-2014
• Double Blind concordance Study Of Colo-Rectal Cancer Treatment Recommendations Between Artificial Intelligence Advisory Programme Watson For Oncolo...
• Anticancer therapy at the end of life of breast, prostate, and colorectal cancer patients
• Financial burden and financial toxicity in patients with colorectal, gastro-oesophageal, and pancreatobiliary cancers: a UK study
• Overview on the use of patient reported outcomes in colorectal cancer care
• Completeness of staging investigation for colorectal cancer: exploring the role of increasing age and comorbidity using mediation analysis
• Is age a barrier to chemotherapy? Rates of treatment in older patients with breast, colon or lung cancer in England in 2014: a national registry study
• New approach to evaluate survival benefit of granulocyte colony-stimulating factor in cancer patients receiving myelosuppressive chemotherapy
• Trajectory of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) predicts time to progression (TTP) in metastatic colorecta...
• Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (M...
• EONS Poster - Peripherally inserted central venous catheters did not increase the risk of deep venous thrombosis in advanced colorectal cancer and...
• Proffered paper session - Gastrointestinal tumours, colorectal - Invited Discussant LBA18_PR and LBA19
• DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD*2A, c.2846A>T...
• Serial circulating tumor DNA analysis for detection of residual disease, assessment of adjuvant therapy efficacy and for early recurrence detection...
• Kinase Fusions in Colorectal Cancers: A Unique Biologic Subset
• A Multi-Omic Analysis for Prospective Patient Stratification in Localised Colorectal Cancer (CRC).
• Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1_) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)
• Long-term Results of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Locally Advanced Rectal C...
• The value of chemotherapy in Stage II colon cancer: much less than we thought
• Folfox and intra-arterial DEBIRI as front-line treatment in patients with non resectable colorectal cancer liver metastases (FFCD 1201 phase II trial)
• Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): post hoc analysis of...
• Profile of individuals who never undergo colorectal cancer screening
• Prospective biomarker study in advanced RAS wild-type colorectal cancer. POSIBA trial.
• Patient selection for targeting integrin with abituzumab in patients with metastatic colorectal cancer (mCRC). A retrospective analysis of the rand...

• « Previous
• 1
• 2
• ...
• 80
• Next »